| Literature DB >> 34379616 |
Guo-Quan Li1, Jing Yang1, Yan Wang2, Mengjun Qiu3, Zeyu Ding1, Sheng Zhang1, Sheng-Li Yang1, Zhenjun Peng4.
Abstract
BACKGROUND In this study, we assessed the usefulness of diaphragm surrogate tracking in the design of a respiratory model for CyberKnife Synchrony treatment of lung tumors. MATERIAL AND METHODS Twenty-four patients with lung cancer who underwent stereotactic body radiotherapy with CyberKnife between April and November 2019 were enrolled. Simulation plans for each patient were designed using Xsight lung tracking (XLT) and diaphragm tracking (DT) methods, and tumor visualization tests were performed. The offset consistency at each respiratory phase was analyzed. The relative distance along the alignment center of the superior-inferior (SI) axis in the 2 projections (dxAB), uncertainty (%), and average standard error (AvgStdErr)/maximum standard error (MAXStdErr) were also analyzed. RESULTS Bland-Altman analyses revealed that the average differences±standard deviation (SD) between XLT and DT tracking methods were 0.4±2.9 mm, 0.3±4.35 mm, and -1.8±6.8 mm for the SI, left-right (LR), and anterior-posterior (AP) directions, respectively. These results indicated high consistency in the SI and LR directions and poor consistency in the AP direction. Uncertainty differed significantly between XLT and DT (22.813±5.721% vs 9.384±3.799%; t=-5.236; P=0.0008), but we found no significant differences in dxAB, AvgStdErr, or MAXStdErr. CONCLUSIONS In the majority of cases, motion tracking by XLT and DT was consistent and synchronized in the SI directions, but not in the LR and AP directions. With a boundary margin of 0.3±4.35 mm and 1.8±6.8 mm for the LR and AP directions, DT may contribute to better implementation of CyberKnife Synchrony treatment in patients with lung tumors near the diaphragm that cannot be seen in tumor visualization tests.Entities:
Mesh:
Year: 2021 PMID: 34379616 PMCID: PMC8366302 DOI: 10.12659/MSM.930139
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Patient characteristics (N=24).
| Characteristics | |
|---|---|
| Age, years | 56 (35–69) |
| Disease, n (%) | |
| Lung cancer | 14 (58.3) |
| Liver cancer | 6 (25) |
| Colorectal cancer | 4 (16.7) |
| Tumor lobe location, n (%) | |
| Right middle lobe | 3 (12.5) |
| Right lower lobe | 12 (50) |
| Left lower lobe | 9 (37.5) |
| Gross tumor volume, cm3 | 17.54 (7.09–36.3) |
| Planning target volume, cm3 | 34.27 (13.04–95.25) |
| Distance between gross tumor volume and diaphragm, mm | 65.28 (27.94–141.53) |
| Total dose, Gy | 45 (35–60) |
| Fraction | 5 (3–8) |
| Treatment time (min) per fraction | 38 (31–54) |
Values are median (range) unless noted otherwise.
Figure 1Sampling sequence during respiration
Figure 2Bland-Altman analysis the offset values between the Xsight lung tracking (XLT) and diaphragm tracking (DT) methods. Consistency analysis of XLT and DT in the (A) superior-inferior, (B) left-right, and (C) anterior-posterior directions.
Figure 3Synchronicity of the 3 translational offsets in patient 1: S-I – superior-inferior; L-R – left-right; and A-P – anterior-posterior.
Figure 4Synchronicity of the 3 translational offsets in patient 2: S-I – superior-inferior; L-R – left-right; and A-P – anterior-posterior.
Comparison of Synchrony model quality parameters between Xsight lung tracking/fiducial tracking (XLT/FT) and diaphragm tracking (DT) (N=24).
| Parameter | XLT/FT | DT | t | P |
|---|---|---|---|---|
| dxAB, mm | 0.664±0.535 | 0.497±0.302 | −0.166 | 0.873 |
| Uncertainty, % | 22.813±5.721 | 9.384±3.799 | −5.236 | 0.0008 |
| AvgStdErr, mm | 1.511±1.007 | 1.767±1.211 | 0.527 | 0.613 |
| MAXStdErr, mm | 1.667±1.038 | 1.900±1.225 | 0.485 | 0.641 |
AvgStdErr – average standard error; dxAB – relative distance along the alignment center of the superior-inferior axis in the 2 projections; MAXStdErr – maximum standard error.
Figure 5Tracking-guided images using (A, B) diaphragm tracking (DT) and (C, D) Xsight lung tracking (XLT).